International and russian experience in treating children’s flu

Author:

Uchaikin V. F.1,Kladova O. V.1,Kharlamova F. S.1,Valts N. L.2,Kompaniets Yu. V.2,Grishkevich N. L.2

Affiliation:

1. Pirogov Russian National Research Medical University of the Ministry of Health of Russia

2. Morozov Children’s City Clinical Hospital of the Moscow Department of Health

Abstract

The article presents an extensive clinical experience about the treatment and prevention of influenza by oseltamivir for children and adults including high-risk group patients through different countries around the world over the past 17 years. The article reveals the causes of resistance to oseltamivir with a relative evolution proportion. The new domestic drug Nomides (oseltamivir), which manufactured by Pharmasintez JSC (Russia) in accordance with the Good Manufacturing Practice (GMP), has been represented in the article by unique dosage forms 30 and 45 mg on the Russian market for childrens older than one years old.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference50 articles.

1. Federal Service for Oversight of Consumer Protection and Welfare Available at: http://www.rospotrebnadzor.ru.

2. Office for National Statistics Available at: http://www.gks.ru.

3. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2017: State report. M.: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2018. 268 p.

4. Enserink M. Bird flu infected 1000, Dutch researchers say. Science, 2004, 306: 590b.

5. Clinical guidelines. Influenza in children. AVI MOO of St. Petersburg and Leningrad region, Eurasian Society for Infectious Diseases MOO, 2017: 43.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Influenza: current topics of etiotropic drug selection;Pediatrics. Consilium Medicum;2022-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3